Fertilo In Vitro Research Study and Trial

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether the use of Fertilo is superior to using Medicult IVM for In vitro maturation. Researchers will compare the number of ongoing pregnancies at 12 weeks gestation for participants in each arm. Arm 1 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Fertilo for 30 hours.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• In Vitro Maturation of Oocytes

Eligibility basics and study details

Study type

Interventional

Phase

Phase 3

Ages

18 to 35 years

Sex

Female

Healthy volunteers

Accepted

Sponsor

Gameto, Inc.

Last updated on ClinicalTrials.gov

October 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites